Skip to main content

Advertisement

Fig. 1 | BMC Cancer

Fig. 1

From: Expression and promotor hypermethylation of miR-34a in the various histological subtypes of ovarian cancer

Fig. 1

miR-34a expression in different clinico-pathologic characteristics. a in grade 1, 2 and 3 ovarian cancers. b in type I and type II tumors (according to the dualistic classification of Kurman et al.). c according to p53 mutational status. d) in low grade serous carcinomas (LGSC) and high grade serous carcinomas (HGSC). P-value is calculated with non-parametric tests (Mann Whitney for between two variable and Kruskal Wallis test between three or more variables. Y-axis represents the value of miR-34a expression as arbitrary unit normalized to TBP

Back to article page